Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner

J Autoimmun. 2021 Sep 1;124:102723. doi: 10.1016/j.jaut.2021.102723. Online ahead of print.ABSTRACTThe initiation and progression of autoimmune disorders such as multiple sclerosis (MS) is linked to aberrant cholesterol metabolism and overt inflammation. Liver X receptors (LXR) are nuclear receptors that function at the crossroads of cholesterol metabolism and immunity, and their activation is considered a promising therapeutic strategy to attenuate autoimmunity. However, despite clear functional heterogeneity and cell-specific expression profiles, the impact of the individual LXR isoforms on autoimmunity remains poorly understood. Here, we show that LXRα and LXRβ have an opposite impact on immune cell function and disease severity in the experimental autoimmune encephalomyelitis model, an experimental MS model. While Lxrα deficiency aggravated disease pathology and severity, absence of Lxrβ was protective. Guided by flow cytometry and by using cell-specific knockout models, reduced disease severity in Lxrβ-deficient mice was primarily attributed to changes in peripheral T cell physiology and occurred independent from alterations in microglia function. Collectively, our findings indicate that LXR isoforms play functionally non-redundant roles in autoimmunity, potentially having broad implications for the development of LXR-based therapeutic strategies aimed at dampening autoimmunity and neuroinflammation.PMID:34481107 | DOI:10.1016/j.jaut.2021.102723

Source: Journal of Autoimmunity - September 4, 2021 Category: Allergy & Immunology Authors: Jeroen F J Bogie Tim Vanmierlo Jasmine Vanmol Silke Timmermans Jo Mailleux Katherine Nelissen Erwin Wijnands Kristiaan Wouters Piet Stinissen Jan- Åke Gustafsson Knut R Steffensen Monique Mulder Noam Zelcer Jerome J A Hendriks Source Type: research